Summit Global Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit Global Investments's AMGN Position: Q2 2026 in Review
Summit Global Investments increased its Amgen (AMGN) stake by 9.5% in Q2 2026, buying an estimated $94.8K and bringing the position to 3,182 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #172.
Summit Global Investments first reported a position in AMGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $4.11M in Q2 2022. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Summit Global Investments held 3,182 shares of Amgen worth $1.15M as of Q2 2026.
- Summit Global Investments bought 277 Amgen shares in Q2 2026, an estimated $94.8K.
- Amgen made up 0.06% of Summit Global Investments's portfolio in Q2 2026, its #172 holding.
- Summit Global Investments first reported a position in Amgen in Q1 2022 and has held it in 11 quarters since.
- Summit Global Investments's Amgen position peaked at $4.11M in Q2 2022.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.